When Monash University announced world-first COVID-19 research in July, the crucial behind-the-scenes work of a group of PhD students went largely unnoticed.
The delivery of a COVID-19 vaccine still needs to overcome some ethical hurdles.
How likely is it that we'll have a relatively quick fix for COVID-19, and what are the hurdles?
Critically ill patients from intensive care units are part of a global trial testing a suite of flu and pneumonia drugs in a bid to combat COVID-19.
Deliberately infecting people with a disease-causing agent as part of medical research can be ethically acceptable, and even necessary.
Dummy text